Never mind the Cash ISA. I think these stock market stalwarts will help you beat a recession

Paul Summers picks out three defensive stocks that should hold their own in the event of a Brexit-linked recession.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Having some cash in the bank is never a bad idea and with more than a few analysts predicting that the UK could slip into recession following Brexit, it’s particularly prudent at the current time.  

Many of us will be using a Cash ISA for this purpose. The fact that these accounts pay interest way below inflation, however, means it’s vital not to leave any surplus funds in there — that is, anything beyond roughly six months of living expenses.

As such, here are three resilient companies I’d consider buying for my portfolio with what’s left over. 

Recession-proof

People will always need medicine, regardless of what the economy is doing. As such, my first port of call is the pharmaceutical industry and, more specifically, GlaxoSmithKline (LSE: GSK). 

Despite the fact that it’s not been increased since 2014, one of the biggest attractions to Glaxo, aside from its defensive qualities, is its dividend. The 80p per share total payout for the current financial year means a yield of almost 4.8%. Perhaps most importantly, the extent to which this cash return is covered by profits is starting to look more stable after a rocky few years. 

Unsurprisingly given the Brexit stand-off, Glaxo’s shares have been steadily growing in popularity, rising 11% since the beginning of 2019. Assuming analysts are correct in their predictions, the shares currently change hands for just over 14 times earnings — far below FTSE 100 peer Astrazeneca’s frothy-looking P/E of 24. 

Another stock that should hold its own in the aftermath of Brexit, if it happens at all, is waste management and recycling firm Biffa (LSE: BIFF).

Last week’s trading update was as no-nonsense as you can get with the company stating that trading over H1 had been in line with management expectations with no change to the outlook for the full year. 

Of course, a business like this will never generate the same level of excitement as your average tech company. On a little less than 10 times earnings, however, I’m tempted to say that Biffa looks cheap.

At its current price, the forecast dividend yield sits close to 3.6% and is easily covered by earnings. There’s quite a bit of debt on the balance sheet (something I usually steer clear of), but the predictability of its line of work arguably makes this less of a red flag.

My last pick is a retailer. That might sound strange considering that consumer confidence is usually battered during economic wobbles, but stick with me.

Here I’m talking about discount retailers — the sort that offer people the most bang for their buck. FTSE 250 member B&M European Value (LSE: BME) is the standout candidate here, especially when recent trading is considered.

In late July, the company stated that it had made a “solid start” to FY20 with group revenue climbing 21.4% over Q1 (31 March-29 June). In sharp contrast to high street peers, 12 new stores were opened over the period with lots more planned over the entire year.

This optimistic outlook goes some way to explaining why B&M’s shares trade on almost 18 times forecast earnings. The 2.4% yield is also the lowest of the three in focus today (although it’s been hiked by double-digits in three of the last four years). With signs that consumers are continuing to tighten the purse strings, however, I think this is still a reasonable price to pay. 

Paul Summers has no position in any of the shares mentioned. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline. The Motley Fool UK owns shares of B&M European Value. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

British pound data
Investing Articles

The red lights are flashing again for Lloyds’ share price! Here’s why

Lloyds' share price continues to defy gravity. But Royston Wild thinks it's only a matter of time before the FTSE…

Read more »

Aston Martin DBX - rear pic of trunk
Investing Articles

Aston Martin shares are now only 41p!

Aston Martin shares just dropped to around the 41p mark! Is this a brilliant buying opportunity or a stock that…

Read more »

Artillery rocket system aimed to the sky and soldiers at sunset.
Investing Articles

Up 325% in 5 years! But are BAE System shares still a no-brainer buy?

BAE Systems shares would have been a brilliant buy five years ago. But could they still offer excellent returns if…

Read more »

Investing Articles

How much do you need to invest each month into FTSE 100 shares to aim for a million?

Simply by putting a few hundred pounds a month into FTSE 100 shares, how might someone aim to become a…

Read more »

Close-up as a woman counts out modern British banknotes.
Investing Articles

£10,000 invested in BAE shares at the beginning of 2026 is now worth…

Paul Summers tips his hat to those who invested in BAE Systems shares when markets opened back up in January.…

Read more »

A senior man and his wife holding hands walking up a hill on a footpath looking away from the camera at the view. The fishing village of Polperro is behind them.
Investing Articles

What size ISA do you need for £250-a-week retirement income?

Harvey Jones outlines the advantages of investing in a Stocks and Shares ISA rather than leaving money in cash, and…

Read more »

Mature Caucasian woman sat at a table with coffee and laptop while making notes on paper
Investing Articles

£5,000 invested in Legal & General shares 5 years ago is now worth…

Harvey Jones crunches the numbers to show how much an investor would have earned from Legal & General shares lately,…

Read more »

Investing Articles

Just check out the latest bumper forecasts for Lloyds, NatWest and Barclays shares

Harvey Jones says Barclays shares have had a terrific year and there could be more action to come. So what's…

Read more »